Amanote Research
Register
Sign In
Respiratory Syncytial Virus Immune Globulin Intravenous: Indications for Use
Pediatrics
- United States
doi 10.1542/peds.99.4.645
Full Text
Open PDF
Abstract
Available in
full text
Categories
Child Health
Pediatrics
Perinatology
Date
April 1, 1997
Authors
Unknown
Publisher
American Academy of Pediatrics (AAP)
Related search
Respiratory Syncytial Virus (RSV) Immune Globulin and Palivizumab for Prevention of RSV Infection
American Journal of Health-System Pharmacy
Medicine
Health Policy
Pharmacology
Pharmacy
Respiratory Syncytial Virus Immune Globulin Treatment of Lower Respiratory Tract Infection in Pediatric Patients Undergoing Bone Marrow Transplantation – A Compassionate Use Experience
Bone Marrow Transplantation
Transplantation
Hematology
RESPIRATORY SYNCYTIAL VIRUS IMMUNE HUMAN GLOBULIN, (RSVIg) AS TREATMENT OF RSV LOWER RESPIRATORY TRACT INFECTIONS (LRI) IN CHILDREN. †1085
Pediatric Research
Child Health
Pediatrics
Perinatology
The Human Immune Response to Respiratory Syncytial Virus Infection
Clinical Microbiology Reviews
Immunology
Environmental
Public Health
Microbiology
Microbiology
Epidemiology
Infectious Diseases
Occupational Health
Respiratory Syncytial Virus
JAMA - Journal of the American Medical Association
Medicine
Respiratory Syncytial Virus
Intravenous Immune Globulin for Statin-Triggered Autoimmune Myopathy
New England Journal of Medicine
Medicine
Respiratory Syncytial Virus and Asthma
Current Opinion in Pediatrics
Child Health
Pediatrics
Perinatology
Intravenous Immunoglobulin Treatment of Respiratory Syncytial Virus Infections in Infants and Young Children.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology